Emmanuel Labourier

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 3

Top Topics

Structural Basis

Fine Needle Aspiration

Coronavirus Disease

Top Venues

Medical oncology (Northwood, London, England)

Pediatric blood & cancer

Diagnostic cytopathology

BMDx Consulting

University of Montpellier (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BMDx Consulting

United States

Founder & Principal

Asuragen Inc.

United States

Senior Director Clinical Development, Director Diagnostics Operations, Associate Director R&D

Ambion Inc.

United States

Group Leader miRNA Technologies, Senior Scientist

University of California Berkeley

United States

Post-Doctoral Research Scientist

Education History

University of Montpellier

France

PHD

Publications

Aime T Franco, Emmanuel Labourier, Kenny Kwabena Ablordeppey, Lea F Surrey, Sogol Mostoufi-Moab, Amber Isaza, N Scott Adzick, Ken Kazahaya, Gyanendra Kumar, Andrew J Bauer
miRNA expression can classify pediatric thyroid lesions and increases the diagnostic yield of mutation testing. Pediatric blood & cancer 67 (6) (2020)
Emmanuel Labourier, Thomas J Fahey
Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature. Diagnostic cytopathology 49 (4) (2020)
Emmanuel Labourier
Efficiency versus effectiveness: impact of molecular testing on healthcare costs and clinical outcome of patients with indeterminate thyroid nodules. Medical oncology (Northwood, London, England) 33 (7) (2016)